A novel fully human anti-NCL immunoRNase for triple-negative breast cancer therapy

Breast cancer is the most common cancer in women worldwide. A new promising anti-cancer therapy involves the use of monoclonal antibodies specific for target tumor-associated antigens (TAAs). A TAA of interest for immunotherapy of Triple Negative Breast Cancer (TNBC) is nucleolin (NCL), a multifunct...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: D'Avino, Chiara, Palmieri, Dario, Braddom, Ashley, Zanesi, Nicola, James, Cindy, Cole, Sara, Salvatore, Francesco, Croce, Carlo M., De Lorenzo, Claudia
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5349967/
https://ncbi.nlm.nih.gov/pubmed/27894092
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13522
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados